Ms. Kim is a technology development professional with a genetic engineering background, passionate about exploring the therapeutic potential of controlled substances. With expertise in the utilization of cutting-edge technologies in engineering and biotechnology, Ms. Kim is committed to drive innovation in the field of therapeutic neuroscience. By collaborating closely with other experts in the field, she actively contributes to the development of innovative technologies for research of neurodegenerative diseases.